Defiance Launches 200% Daily Leveraged ETF for Rocket Companies as Shares Break $21.65
Defiance ETFs launched RKTL, a daily 2X long ETF aiming to deliver 200% of Rocket Companies’ daily share-price changes, granting traders amplified exposure and boosting RKT’s trading volatility. RKT shares rallied over 10% after President Trump’s mortgage bond purchase plan triggered a breakout above $21.65 resistance.
1. Launch of Defiance Daily Target 2X Long RKT ETF Expands Leveraged Suite
On January 13, 2026, Defiance ETFs rolled out the Defiance Daily Target 2X Long RKT ETF, marking its first product focused on amplifying daily moves in Rocket Companies, Inc. The new fund seeks to deliver twice the daily percentage change in Rocket Companies’ share price, catering to active traders who pursue short-term, high-volatility strategies. As a single-stock leveraged ETF, it joins Defiance’s existing lineup of nine single-stock products, bringing total assets under management in that category to over $1.2 billion. The fund will employ swap and options contracts to achieve its 200% daily exposure and is managed by Tidal Investments, LLC, with Defiance ETFs LLC as sponsor. Investors should note that this product is designed strictly for daily use and may not track the underlying stock over longer horizons due to compounding effects.
2. Investor Risks and Suitability for Aggressive Traders
Defiance emphasizes that the 2X long ETF is intended only for knowledgeable investors who actively monitor positions and understand leveraged strategies. The fund carries heightened risks compared to unleveraged alternatives: in a single trading session, losses can exceed 100% of initial capital if the underlying stock moves sharply against the fund’s position. Key risk factors include volatility decay, counterparty exposure from derivatives, lack of diversification since the ETF holds no other equities, and potential tracking error. The prospectus warns that daily rebalancing may result in performance divergence over multi-day periods, and that market disruptions or rebalancing failures could significantly skew returns. As such, the product is unsuitable for buy-and-hold investors or those unable to review holdings intra-day.